Apotex Health Corp. (APTX) Opens the Market

• The most recent release (June 11, 2026) details the official market opening and bell-ringing ceremony for Apotex Health Corp. (APTX) on the Toronto Stock Exchange.
• This ceremonial event follows the successful pricing of its upsized IPO on June 9 at $24.00 per share, which raised $1.3 billion in gross proceeds.
• The capital raise is structured as a primary treasury offering (~$850M to Apotex) and a secondary offering by existing shareholders (~$450M), with an over-allotment option for up to 8.125M additional shares.
• The announcement highlights the company's position as the largest Canadian-based pharmaceutical firm and its global operational footprint across the Americas.

• The bell-ringing ceremony is a procedural milestone that confirms the completion of the listing process initiated on June 10. It carries no new financial, operational, or strategic data.
• The material pricing event occurred on June 9-10. The stock opened at $27.00 on June 10, reflecting a 12.5% premium over the $24.00 IPO price. This pop indicates strong initial demand and successful execution.
• The $1.3B gross raise significantly strengthens the balance sheet, providing substantial liquidity for future acquisitions, R&D, and debt reduction. However, the June 11 news itself does not alter the capital structure or valuation.

• Apotex Health Corp. is the largest Canadian-based pharmaceutical company, headquartered in Toronto with regional offices in the US, Mexico, and India.
• The company operates across generic, biosimilar, and innovative branded pharmaceuticals, alongside consumer health products.
• It holds a strategic position as a preferred health partner in the Americas for pharmaceutical licensing and product acquisitions.
• The company is backed by major private equity owners, including SK Artemis Holdings, II, LLC (~54.3% post-IPO) and API Investment LP (~14.0%).